Female Chronic Pelvic Pain
Launched by COPENHAGEN UNIVERSITY HOSPITAL AT HERLEV · Dec 6, 2010
Trial Information
Current as of May 27, 2025
Unknown status
Keywords
ClinConnect Summary
Introduction:
The aim of this study is to investigate the frequency and severity of chronic pelvic pain (CPP) in adult women living in Copenhagen Country and Zealand Country (total population 2,4 million), Denmark, in relation to selected factors, such as basic demographic and clinical factors, health related quality of life, physical activity and abnormal muscular findings in the pelvic area.
Methods:
The study is designed as a cross-sectional, questionnaire-based survey and two randomly selected age stratified groups of the responding participating women, one with or one without pain, ...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women ≥ 18 years
- • Living in Copenhagen Country (Region H)
- • Capable of reading, writing and speaking Danish
- Exclusion Criteria:
- • Pain limited solely to the perineal skin or introitus (vulvodynia)
- • Pregnancy, cancer, active pelvic inflammatory disease
- • Operation in the pelvic during the last 6 months
- • Cognitively impaired individuals
About Copenhagen University Hospital At Herlev
Copenhagen University Hospital at Herlev is a leading academic medical center in Denmark, dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the hospital leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous studies aimed at improving patient outcomes and advancing medical knowledge. With a strong commitment to ethical standards and patient safety, Copenhagen University Hospital at Herlev collaborates with researchers, healthcare professionals, and industry partners to explore new treatment modalities and enhance the standard of care across various medical fields.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Herlev, Copenhagen, Denmark
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials